Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Old-Age Blindness Risk Explained

Condition attributed to gene mutation that impedes binding of malondialdehyde to gene protein

by Sarah Everts
October 10, 2011 | A version of this story appeared in Volume 89, Issue 41

Researchers have finally figured out why people who have a single mutation in a gene called CFH are at serious risk for age-related macular degeneration, or AMD (Nature, DOI: 10.1038/nature10449). Some two-thirds of people over the age of 80 will get AMD (Nature, DOI: 10.1038/478042a), which is caused by the buildup of cell waste on the retina from the continuous barrage of photons on the eye. Now, Christoph J. Binder, a medical researcher at the Austrian Academy of Sciences, in Vienna, and colleagues have discovered that the CFH mutation impedes the binding of the CFH protein and a common photodegradation product called malondialdehyde. When this binding can’t occur, malondialdehyde cannot be cleared from the surface of the retina and builds up, causing AMD. “By combining in vitro and in vivo data from human patients and animal models, the authors provide a plausible explanation for the cause of this devastating chronic disease,” note University of Miami researchers Fernando Cruz-Guilloty and Victor L. Perez in an associated commentary.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.